At AAPS PharmSci 360 2025, held from Nov. 9–12 in San Antonio, Texas, Corey Bloom, PhD, associate director, CMC (chemistry, ...
Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2026
New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across Multiple ...
Zydus Lifesciences Ltd and Torrent Pharmaceuticals Ltd are preparing to enter the fast-growing market for Semaglutide — a ...
Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsMarDee Haring-Layton - Chief Accounting ...
Company to offer the first clinically validated dietary management of sarcopenia, now available for GLP-1 muscle loss, positioning Wellgistics to help 6,500+ independent pharmacy network (‘Pharmacy ...
New NIAID Non-Dilutive Funding Award of up to US $40Million with US$90 Million in Pending Proposals Across Multiple Infectious Disease Programs LIKMEZ® (ATI-1501): Building Commercial Momentum in the ...
LAHORE: The Small and Medium Enterprises Development Authority (SMEDA) and the Pakistan Bureau of Statistics (PBS) have ...
Fiera Cosmetics has created a solution with their All-in-Wonder™ Concealer + Foundation that addresses these exact concerns, which explains why so many women are making the switch from products like ...
Officials at the F.M. Kirby Center for the Performing Arts want to hear your thoughts on what would make Downtown ...
Operator: Good morning, and welcome to BiomX Third Quarter 2025 Financial Results and Program Update Conference Call.
Silexion continues to advance operational readiness for its planned Phase 2/3 clinical trials of SIL204, with toxicology ...
Panabo City PCEDIPC successfully finished a workshop to formulate its Investment Promotion Roadmap (2026-2030). The blueprint aims to attract sustainable and high-impact investments and create jobs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results